Nuclear export regulation of COP1 by 14-3-3σ in response to DNA damage

Molecular Cancer

Volumn 9, Issue , 2010, Pages

  Su, Chun Hui ^a,b   Zhao, Ruiying ^a,b   Velazquez Torres, Guermarie ^a,b   Chen, Jian ^a   Gully, Christopher ^a   Yeung, Sai Ching J ^a   Lee, Mong Hong ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; STRATIFIN; UBIQUITIN PROTEIN LIGASE COP1; PROTEIN 14 3 3; RFWD2 PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE;

AMINO TERMINAL SEQUENCE; ARTICLE; BIOACCUMULATION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DNA DAMAGE; ENZYME INHIBITION; HUMAN; HUMAN CELL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REGULATORY MECHANISM; UBIQUITINATION; ACTIVE TRANSPORT; CELL LINE; GENETICS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; METABOLISM; PHYSIOLOGY;

MAMMALIA;

14-3-3 PROTEINS; ACTIVE TRANSPORT, CELL NUCLEUS; CELL LINE; CELL NUCLEUS; CYTOPLASM; DNA DAMAGE; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; PROTEIN BINDING; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 77956534974     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-9-243     Document Type: Article

References (26)

1. Hardtke CS, Gohda K, Osterlund MT, Oyama T, Okada K, Deng XW. HY5 stability and activity in arabidopsis is regulated by phosphorylation in its COP1 binding domain. Embo J 2000, 19:4997-5006. 10.1093/emboj/19.18.4997, 314229, 10990463.
2. Dornan D, Wertz I, Shimizu H, Arnott D, Frantz GD, Dowd P, O'Rourke K, Koeppen H, Dixit VM. The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 2004, 429:86-92. 10.1038/nature02514, 15103385.
3. Bianchi E, Denti S, Catena R, Rossetti G, Polo S, Gasparian S, Putignano S, Rogge L, Pardi R. Characterization of human constitutive photomorphogenesis protein 1, a RING finger ubiquitin ligase that interacts with Jun transcription factors and modulates their transcriptional activity. J Biol Chem 2003, 278:19682-19690. 10.1074/jbc.M212681200, 12615916.
4. Wertz IE, O'Rourke KM, Zhang Z, Dornan D, Arnott D, Deshaies RJ, Dixit VM. Human De-etiolated-1 regulates c-Jun by assembling a CUL4A ubiquitin ligase. Science 2004, 303:1371-1374. 10.1126/science.1093549, 14739464.
5. Savio MG, Rotondo G, Maglie S, Rossetti G, Bender JR, Pardi R. COP1 D, an alternatively spliced constitutive photomorphogenic-1 (COP1) product, stabilizes UV stress-induced c-Jun through inhibition of full-length COP1. Oncogene 2008, 27:2401-2411. 10.1038/sj.onc.1210892, 17968316.
6. Dentin R, Liu Y, Koo SH, Hedrick S, Vargas T, Heredia J, Yates J, Montminy M. Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2. Nature 2007, 449:366-369. 10.1038/nature06128, 17805301.
7. Kato S, Ding J, Pisck E, Jhala US, Du K. COP1 functions as a FoxO1 ubiquitin E3 ligase to regulate FoxO1-mediated gene expression. J Biol Chem 2008, 283:35464-35473. 10.1074/jbc.M801011200, 2602905, 18815134.
8. Li DQ, Ohshiro K, Reddy SD, Pakala SB, Lee MH, Zhang Y, Rayala SK, Kumar R. E3 ubiquitin ligase COP1 regulates the stability and functions of MTA1. Proc Natl Acad Sci USA 2009, 106:17493-17498. 10.1073/pnas.0908027106, 2762678, 19805145.
9. Dornan D, Shimizu H, Mah A, Dudhela T, Eby M, O'Rourke K, Seshagiri S, Dixit VM. ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage. Science 2006, 313:1122-1126. 10.1126/science.1127335, 16931761.
10. Lee MH, Lozano G. Regulation of the p53-MDM2 pathway by 14-3-3 sigma and other proteins. Semin Cancer Biol 2006, 16:225-234. 10.1016/j.semcancer.2006.03.009, 16697215.
11. Fu H, Subramanian RR, Masters SC. 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol 2000, 40:617-647. 10.1146/annurev.pharmtox.40.1.617, 10836149.
12. Michaud NR, Fabian JR, Mathes KD, Morrison DK. 14-3-3 is not essential for Raf-1 function: identification of Raf-1 proteins that are biologically activated in a 14-3-3-and Ras-independent manner. Mol Cell Biol 1995, 15:3390-3397. 230573, 7760835.
13. Prasad GL, Valverius EM, McDuffie E, Cooper HL. Complementary DNA cloning of a novel epithelial cell marker protein, HME1, that may be downregulated in neoplastic mammary cells. Cell Growth Differ 1992, 3:507-513.
14. Verdoodt B, Benzinger A, Popowicz GM, Holak TA, Hermeking H. Characterization of 14-3-3sigma dimerization determinants: requirement of homodimerization for inhibition of cell proliferation. Cell Cycle 2006, 5:2920-2926.
15. Li Z, Liu JY, Zhang JT. 14-3-3sigma, the double-edged sword of human cancers. Am J Transl Res 2009, 1:326-340. 2780041, 19956445.
16. Yang HY, Wen YY, Chen CH, Lozano G, Lee MH. 14-3-3 sigma positively regulates p53 and suppresses tumor growth. Mol Cell Biol 2003, 23:7096-7107. 10.1128/MCB.23.20.7096-7107.2003, 230310, 14517281.
17. Yang HY, Wen YY, Lin YI, Pham L, Su CH, Yang H, Chen J, Lee MH. Roles for negative cell regulator 14-3-3sigma in control of MDM2 activities. Oncogene 2007, 26:7355-7362. 10.1038/sj.onc.1210540, 17546054.
18. Yang H, Wen YY, Zhao R, Lin YL, Fournier K, Yang HY, Qiu Y, Diaz J, Laronga C, Lee MH. DNA damage-induced protein 14-3-3 sigma inhibits protein kinase B/Akt activation and suppresses Akt-activated cancer. Cancer Res 2006, 66:3096-3105. 10.1158/0008-5472.CAN-05-3620, 16540659.
19. Laronga C, Yang HY, Neal C, Lee MH. Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression. J Biol Chem 2000, 275:23106-23112. 10.1074/jbc.M905616199, 10767298.
20. Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, Thiagalingam S, Kinzler KW, Vogelstein B. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell 1997, 1:3-11. 10.1016/S1097-2765(00)80002-7, 9659898.
21. Chan TA, Hermeking H, Lengauer C, Kinzler KW, Vogelstein B. 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature 1999, 401:616-620. 10.1038/44188, 10524633.
22. Yaffe MB, Rittinger K, Volinia S, Caron PR, Aitken A, Leffers H, Gamblin SJ, Smerdon SJ, Cantley LC. The structural basis for 14-3-3:phosphopeptide binding specificity. Cell 1997, 91:961-971. 10.1016/S0092-8674(00)80487-0, 9428519.
23. Ziv Y, Bar-Shira A, Pecker I, Russell P, Jorgensen TJ, Tsarfati I, Shiloh Y. Recombinant ATM protein complements the cellular A-T phenotype. Oncogene 1997, 15:159-167. 10.1038/sj.onc.1201319, 9244351.
24. Osterlund MT, Wei N, Deng XW. The roles of photoreceptor systems and the COP1-targeted destabilization of HY5 in light control of Arabidopsis seedling development. Plant Physiol 2000, 124:1520-1524. 10.1104/pp.124.4.1520, 1539307, 11115869.
25. Osterlund MT, Hardtke CS, Wei N, Deng XW. Targeted destabilization of HY5 during light-regulated development of Arabidopsis. Nature 2000, 405:462-466. 10.1038/35013076, 10839542.
26. Stommel JM, Wahl GM. Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation. Embo J 2004, 23:1547-1556. 10.1038/sj.emboj.7600145, 391059, 15029243.